K
Kaya Bilguvar
Researcher at Yale University
Publications - 152
Citations - 19211
Kaya Bilguvar is an academic researcher from Yale University. The author has contributed to research in topics: Exome sequencing & Exome. The author has an hindex of 48, co-authored 138 publications receiving 14032 citations. Previous affiliations of Kaya Bilguvar include Marmara University & Acıbadem University.
Papers
More filters
Journal ArticleDOI
Erratum to Mutations in KATNB1 Cause Complex Cerebral Malformations by Disrupting Asymmetrically Dividing Neural Progenitors[Neuron, 84, 1226-1239, 2014]
Ketu Mishra-Gorur,Ahmet Okay Caglayan,Ashleigh E. Schaffer,Chiswili Chabu,Octavian Henegariu,Fernando Vonhoff,Gozde Tugce Akgumus,Sayoko Nishimura,Wenqi Han,Shu Tu,Burçin Baran,Hakan Gümüş,Cengiz Dilber,Maha S. Zaki,Heba A.A. Hossni,Jean Baptiste Rivière,Hülya Kayserili,Emily Spencer,Rasim Ozgur Rosti,Jana Schroth,Hüseyin Per,Caner Çağlar,Çağri Çağlar,Duygu Dölen,Jacob F Baranoski,Sefer Kumandaş,Frank J. Minja,E. Zeynep Erson-Omay,Shrikant Mane,Richard P. Lifton,Tian Xu,Haig Keshishian,William B. Dobyns,Neil C. Chi,Nenad Sestan,Angeliki Louvi,Kaya Bilguvar,Katsuhito Yasuno,Joseph G. Gleeson,Murat Gunel +39 more
TL;DR: This study presents a novel and scalable approach to genome analysis that aims to provide real-time information about the “building blocks” of Alzheimer’s disease and its progression through childhood and adolescence.
Journal ArticleDOI
A rare case of congenital fibrosis of extraocular muscle type 1A due to KIF21A mutation with Marcus Gunn jaw-winking phenomenon.
Ayşe Kaçar Bayram,Hüseyin Per,Jennifer L. Quon,Mehmet Canpolat,Ege Ülgen,Hakki Dogan,Hakan Gümüş,Sefer Kumandaş,Nurettin Bayram,Kaya Bilguvar,Ahmet Okay Caglayan +10 more
TL;DR: This is first report of the coexistence of CFEOM and Marcus Gunn jaw-winking phenomenon in a patient with a KIF21A mutation from Turkey.
Journal ArticleDOI
ALG13 X‐linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes
Hind Alsharhan,Hind Alsharhan,Miao He,Andrew C. Edmondson,Earnest James Paul Daniel,Jie Chen,Tyhiesia Donald,Somayeh Bakhtiari,Somayeh Bakhtiari,David J. Amor,Elizabeth Jones,Elizabeth Jones,Grace Vassallo,Marie Vincent,Benjamin Cogné,Wallid Deb,Arend H. Werners,Sheng Chih Jin,Kaya Bilguvar,John Christodoulou,John Christodoulou,Richard Webster,Katherine Yearwood,Bobby G. Ng,Hudson H. Freeze,Michael C. Kruer,Michael C. Kruer,Dong Li,Kimiyo Raymond,Elizabeth J. Bhoj,Andrew K. Sobering +30 more
TL;DR: In this article, a semi-quantitative flow injection-electrospray ionization-quadrupole time-of-flight mass spectrometry (ESI-QTOF/MS) N-glycan assay was used to detect subtle abnormalities in N glycans that normally account for <0.3% of the total plasma glycans that may increase up to 0.5% in females with the p(Asn107Ser) variant.
Journal ArticleDOI
Biallelic loss-of-function variants in the splicing regulator NSRP1 cause a severe neurodevelopmental disorder with spastic cerebral palsy and epilepsy.
Daniel G. Calame,Daniel G. Calame,Somayeh Bakhtiari,Somayeh Bakhtiari,Rachel Logan,Zeynep Coban-Akdemir,Zeynep Coban-Akdemir,Haowei Du,Tadahiro Mitani,Jawid M Fatih,Jill V. Hunter,Jill V. Hunter,Isabella Herman,Isabella Herman,Davut Pehlivan,Davut Pehlivan,Shalini N. Jhangiani,Richard E. Person,Rhonda E. Schnur,Sheng Chih Jin,Kaya Bilguvar,Jennifer E. Posey,Sookyong Koh,Saghar Ghasemi Firouzabadi,Elham Alehabib,Abbas Tafakhori,Sahra Esmkhani,Richard A. Gibbs,Mahmoud M Noureldeen,Maha S. Zaki,Dana Marafi,Dana Marafi,Hossein Darvish,Michael C. Kruer,Michael C. Kruer,James R. Lupski +35 more
TL;DR: In this article, the authors identified six patients from three unrelated families with homozygous loss-of-function variants in NSRP1, which is a ubiquitously expressed splicing regulator not known to underlie a Mendelian disorder.
Journal ArticleDOI
Bi-allelic variants in SPATA5L1 lead to intellectual disability, spastic-dystonic cerebral palsy, epilepsy, and hearing loss.
Elodie Richard,Somayeh Bakhtiari,Somayeh Bakhtiari,Ashley P.L. Marsh,Ashley P.L. Marsh,Rauan Kaiyrzhanov,Matias Wagner,Sheetal Shetty,Sheetal Shetty,Alex M. Pagnozzi,Sandra M. Nordlie,Sandra M. Nordlie,Brandon S. Guida,Brandon S. Guida,Patricia Cornejo,Patricia Cornejo,Patricia Cornejo,Helen Magee,Helen Magee,James Liu,James Liu,Bethany Y. Norton,Bethany Y. Norton,Richard Webster,Lisa Worgan,Hakon Hakonarson,Jiankang Li,Yiran Guo,Mahim Jain,Alyssa Blesson,Lance H. Rodan,Mary Alice Abbott,Anne M. Comi,Anne M. Comi,Julie S. Cohen,Julie S. Cohen,Bader Alhaddad,Thomas Meitinger,Dominic Lenz,Andreas Ziegler,Urania Kotzaeridou,Theresa Brunet,Anna Chassevent,Constance Smith-Hicks,Constance Smith-Hicks,Joseph Ekstein,Tzvi Weiden,Andreas Hahn,Nazira Zharkinbekova,Peter D. Turnpenny,Arianna Tucci,Melissa Yelton,Rita Horvath,Serdal Güngör,Semra Hiz,Yavuz Oktay,Hanns Lochmüller,Marcella Zollino,Manuela Morleo,Giuseppe Marangi,Vincenzo Nigro,Annalaura Torella,Michele Pinelli,Simona Amenta,Ralf A. Husain,Benita Grossmann,Marion Rapp,Claudia Steen,Iris Marquardt,Mona Grimmel,Ute Grasshoff,G. Christoph Korenke,Marta Owczarek-Lipska,John Neidhardt,Francesca Clementina Radio,Cecilia Mancini,Dianela Judith Claps Sepulveda,Kirsty McWalter,Amber Begtrup,Amy Crunk,Maria J. Guillen Sacoto,Richard E. Person,Rhonda E. Schnur,Maria Margherita Mancardi,Florian Kreuder,Pasquale Striano,Pasquale Striano,Federico Zara,Federico Zara,Wendy K. Chung,Warren A. Marks,Clare L. van Eyk,Dani L. Webber,Mark A. Corbett,Kelly Harper,Jesia G. Berry,Alastair H. MacLennan,Jozef Gecz,Marco Tartaglia,Vincenzo Salpietro,Vincenzo Salpietro,John Christodoulou,John Christodoulou,Jan Kaslin,Sergio Padilla-Lopez,Sergio Padilla-Lopez,Kaya Bilguvar,Alexander Münchau,Zubair M. Ahmed,Robert B. Hufnagel,Michael C Fahey,Reza Maroofian,Henry Houlden,Heinrich Sticht,Shrikant Mane,Aboulfazl Rad,Barbara Vona,Sheng Chih Jin,Tobias B. Haack,Christine Makowski,Yoel Hirsch,Saima Riazuddin,Michael C. Kruer,Michael C. Kruer +123 more
TL;DR: In this paper, the authors reported 28 bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss in 47 individuals from 28 (26 unrelated) families, and 25/47 affected individuals presented with microcephaly, developmental delay/intellectual disability, cerebral palsy, and/or epilepsy.